CLCC François Baclesse

Caen 14075

1 studies enrolling now · 1 studies all time

What they study most

Advanced Solid Tumor

Studies at this site

• A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors — Recruiting now